Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-24

Clinical Trial Update: Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating three oral doses of Florence suspension for efficacy and safety in adults with eosinophilic esophagitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Florence oral suspension (Florence oral suspension)

Snippet

Sponsor: EMS | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: UNKNOWN